Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics of IDB-011 for Rift Valley Fever is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rift Valley Fever

Drugs mentioned

• IDB-011

Snippet

Sponsor: IDBiologics, Inc. | Conditions: Rift Valley Fever | Phase 1 | Status: ACTIVE_NOT_RECRUITING